Registration Frequencies

Weekly updated frequencies of observation starts at registration by medication are shown.

Fig 1) Patient numbers by biologic treatment at inclusion
Last update: 24. April| total n= 25,259
Fig 1) Patient numbers by biologic treatment at inclusion

 

Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion
Last update: 24. April| total n= 25,259
Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion

 

Show table for Fig. 1/2Hide table

Finaler Code Englisch

Inclusion Treatment Patient Number of that with similar agents (e.g. Biosimilars)
Adalimumab 1081 1433
Bimekizumab 386 0
Brodalumab 589 0
Certolizumab 234 0
Efalizumab 35 0
Etanercept 312 72
Golimumab 25 0
Guselkumab 1863 0
Infliximab 102 1
Ixekizumab 1024 0
Risankizumab 1857 0
Secukinumab 2120 0
Tildrakizumab 1607 0
Ustekinumab 781 6
Apremilast 772 0
Ciclosporin 402 0
Deucravacitinib 209 0
Fumaric acid esters 2694 0
Dimethyl fumarate 3366 0
Methotrexate 3923 0
Tofacitinib 2 0
Upadacitinib 7 0
other systemics 356 0

 

Fig. 3) Rate of patients by medication class at inclusion
Last update: 24. April| total n= 25,259
Fig. 3) Rate of patients by medication class at inclusion

 

Fig. 4) Rate of patients by type of registry site
Last update: 24. April| total n= 25,259
Fig. 4) Rate of patients by type of registry site

 

Fig. 5) Registered PsoBest centers
Last update: 16. April| n= 1,191| updated monthly
Fig. 5) Registered PsoBest centers